Kistler-Tiffany Companies’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Kistler-Tiffany Companies’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,200	Closed	-$380K	–	663
2015 Q1	$380K	Hold	2,200	–	–	0.24%	71
2014 Q4	$253K	Hold	2,200	–	–	0.17%	91
2014 Q3	$344K	Hold	2,200	–	–	0.23%	76
2014 Q2	$271K	Hold	2,200	–	–	0.2%	83
2014 Q1	$228K	Sell	2,200 -1,000	-31%	-$102K	0.17%	90
2013 Q4	$288K	Hold	3,200	–	–	0.22%	78
2013 Q3	$214K	Hold	3,200	–	–	0.17%	92
2013 Q2	$212K	Buy	+3,200	New	+$183K	0.18%	90

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Kistler-Tiffany Companies's SLXP Position: Q2 2015 in Review

Kistler-Tiffany Companies sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 2,200 shares — an estimated $380K sold.

Kistler-Tiffany Companies first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $380K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Kistler-Tiffany Companies reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Kistler-Tiffany Companies sold 2,200 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $380K.
Kistler-Tiffany Companies first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Kistler-Tiffany Companies's SALIX PHARMACEUTICALS LTD DEL position peaked at $380K in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2015, filed 13 Jul 2015.